2seventy bio Inc (TSVT)
4.945
+0.18
(+3.89%)
USD |
NASDAQ |
May 06, 16:00
4.945
0.00 (0.00%)
After-Hours: 17:57
2seventy bio Enterprise Value: 27.25M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 27.25M |
| May 02, 2024 | 35.97M |
| May 01, 2024 | 19.04M |
| April 30, 2024 | 16.99M |
| April 29, 2024 | 18.53M |
| April 26, 2024 | 1.340M |
| April 25, 2024 | 3.136M |
| April 24, 2024 | 2.109M |
| April 23, 2024 | 20.58M |
| April 22, 2024 | 21.61M |
| April 19, 2024 | 14.94M |
| April 18, 2024 | 21.09M |
| April 17, 2024 | 42.65M |
| April 16, 2024 | 32.38M |
| April 15, 2024 | 38.80M |
| April 12, 2024 | 41.62M |
| April 11, 2024 | 66.25M |
| April 10, 2024 | 51.37M |
| April 09, 2024 | 71.89M |
| April 08, 2024 | 65.74M |
| April 05, 2024 | 35.46M |
| April 04, 2024 | 40.08M |
| April 03, 2024 | 38.54M |
| April 02, 2024 | 36.49M |
| April 01, 2024 | 80.10M |
| Date | Value |
|---|---|
| March 28, 2024 | 57.53M |
| March 27, 2024 | 59.06M |
| March 26, 2024 | 37.51M |
| March 25, 2024 | 34.44M |
| March 22, 2024 | 46.24M |
| March 21, 2024 | 39.05M |
| March 20, 2024 | 15.96M |
| March 19, 2024 | 13.40M |
| March 18, 2024 | -1.996M |
| March 15, 2024 | -11.24M |
| March 14, 2024 | -13.80M |
| March 13, 2024 | -11.23M |
| March 12, 2024 | 25.71M |
| March 11, 2024 | 18.02M |
| March 08, 2024 | 25.20M |
| March 07, 2024 | 59.06M |
| March 06, 2024 | 73.94M |
| March 05, 2024 | 80.10M |
| March 04, 2024 | 61.12M |
| March 01, 2024 | 72.41M |
| February 29, 2024 | 49.83M |
| February 28, 2024 | 58.45M |
| February 27, 2024 | 84.78M |
| February 26, 2024 | 61.49M |
| February 23, 2024 | 55.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-171.14M
Minimum
Nov 21 2023
994.59M
Maximum
Nov 09 2021
158.20M
Average
144.73M
Median
Jan 12 2023
Enterprise Value Benchmarks
| Bristol-Myers Squibb Co | 135.24B |
| Johnson & Johnson | 366.66B |
| Macrogenics Inc | 748.50M |
| Akebia Therapeutics Inc | 278.90M |
| Tango Therapeutics Inc | 475.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -56.82M |
| Revenue (Quarterly) | 10.68M |
| Total Expenses (Quarterly) | 70.56M |
| EPS Diluted (Quarterly) | -1.11 |
| Gross Profit Margin (Quarterly) | 70.54% |
| Profit Margin (Quarterly) | -531.8% |
| Earnings Yield | -89.38% |
| Normalized Earnings Yield | -81.12 |